- What's Tisch?
- Stem Cell Trial
- Get Involved
Saud A. Sadiq, MD, and Christen Shoesmith, MD, FRCPC
Neurology® 2019;93:1-2. doi:10.1212/WNL.0000000000008613
Considered an expert in regenerative medicine, Tisch MS Research Center of New York's Director and Chief Research Scientist Dr. Saud A. Sadiq was invited to review the use of stem cells in amyotrophic lateral sclerosis (ALS).
Research performed at Massachusetts General Hospital Neurological Clinical Research Institute (NCRI) under the direction of James Berry, MD et al.
TO READ FULL REVIEW PLEASE EMAIL A REQUEST TO: email@example.com